Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |